Skip to main content
SpringerLink
Log in

Co-evolutionary Perspective on Sourcing Portfolios: Examining Sourcing Choices for Clinical Trials of Bio-pharmaceutical Firms

  • Research Article
  • Published:
Management International Review Aims and scope Submit manuscript

Abstract

Firms in many industries are faced with challenges in effectively managing their sourcing portfolios, defined as a firm’s collection of different sourcing choices (e.g., domestic in-house, domestic outsourcing, offshore outsourcing and captive offshoring) used to conduct a particular value-chain activity. While existing research provides valuable insights on the key factors driving firms’ decision-making regarding individual sourcing choice, important questions remain regarding antecedents and the evolution of portfolios of sourcing choices. We adopt a co-evolutionary perspective to answer the questions of how firms configure their sourcing portfolios, and what triggers changes in these configurations over time. In this study, we examine changes in bio-pharmaceutical firms’ sourcing portfolios for clinical trials. Based on qualitative case study analysis of four firms in this industry, we identify and track changes in internal and external processes of variation, selection and retention. Our study contributes to the co-evolutionary perspective on offshoring and outsourcing by refining the organizational level of analysis to consider portfolios as an important unit of analysis, and also by identifying evolutionary processes and mapping an evolutionary trajectory of changes in sourcing portfolios.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Notes

  1. Our search in the Web of Science database for years 1900–2017 using key words ‘backsource*’, ‘back-source*’ or ‘reinsource*’ yielded 39 publications total with only 12 publications in the area of Management, Business and Economics that are relevant for our study.

  2. Orphan drugs are drugs which treat rare diseases. According to the Orphan Drug Act of 1982, any drug which has efficacy against a disease affecting fewer than 200,000 people in the US is known as an orphan drug (Bruyaka et al. 2013; Haffner 2006).

References

  • Agarwal, S., & Ramaswami, S. N. (1992). Choice of foreign market entry mode: Impact of ownership, location and internalization factors. Journal of International Business Studies, 23(1), 1–27.

    Article  Google Scholar 

  • Alcacer, J., & Chung, W. (2007). Location strategies and knowledge spillovers. Management Science, 53(5), 760–776.

    Article  Google Scholar 

  • Alexender, M., & Young, D. (1996). Strategic Outsourcing. Long Range Planning, 29(1), 116–119.

    Article  Google Scholar 

  • Amaral, J., Billington, C. A., & Tsay, A. A. (2006). Safeguarding the promise of production outsourcing. Interfaces, 36(3), 220–233.

    Article  Google Scholar 

  • Azoulay, P. (2004). Capturing knowledge within and across firm boundaries: evidence from clinical development. The American Economic Review, 94(5), 1591–1612.

    Article  Google Scholar 

  • Baier, E., Rammer, C., & Schubert, T. (2015). The impact of captive innovation offshoring on the effectiveness of organizational adaptation. Journal of International Management, 21(2), 150–165.

    Article  Google Scholar 

  • Bardhan, A. D. (2006). Managing globalization of R&D: Organizing for offshoring innovation. Human Systems Management, 25(2), 103–114.

    Google Scholar 

  • Barge-Gil, A., & López, A. (2014). R&D determinants: accounting for the differences between research and development. Research Policy, 43(9), 1634–1648.

    Article  Google Scholar 

  • Benito, G. R., Petersen, B., & Welch, L. S. (2011). Mode combinations and international operations. Management International Review, 51(6), 803–820.

    Article  Google Scholar 

  • Bhagwatwar, A., Hackney, R., & Desouza, K. C. (2011). Considerations for information systems “backsourcing”: a framework for knowledge re-integration. Information Systems Management, 28(2), 165–173.

    Article  Google Scholar 

  • Bingham, C. B., & Kahl, S. J. (2013). The process of schema emergence: Assimilation, deconstruction, unitization and the plurality of analogies. Academy of Management Journal, 56(1), 14–34.

    Article  Google Scholar 

  • Birkinshaw, J. (1995). How multinational subsidiary mandates are gained and lost. Journal of International Business Studies, 27(3), 467–495.

    Article  Google Scholar 

  • Blau, P. M. (1977). Inequality and heterogeneity: A primitive theory of social structure (Vol. 7). New York: Free Press.

    Google Scholar 

  • Brouthers, K. D. (2002). Institutional, cultural and transaction cost influences on entry mode choice and performance. Journal of International Business Studies, 33(2), 203–222.

    Article  Google Scholar 

  • Bruyaka, O., & Durand, R. (2012). Sell-off or shut-down? Alliance portfolio diversity and two types of high tech firms’ exit. Strategic Organization, 10(1), 7–30.

    Article  Google Scholar 

  • Bruyaka, O., Zeitzmann, H., Chalamon, I., Wokutch, R., & Thakur, P. (2013). Strategic corporate responsibility and orphan drug development: Insights from the US and the EU Bio-pharmaceutical industry. Journal of Business Ethics, 117(1), 45–65.

    Article  Google Scholar 

  • Caner, T., Bruyaka, O., & Prescott, J. E. (2016). Flow signals: Evidence from patent and alliance portfolios in the US bio-pharmaceutical industry. Journal of Management Studies. doi:10.1111/joms.12217.

    Google Scholar 

  • Cantwell, J. (1995). The globalization of technology: what remains of the product cycle model? Cambridge Journal of Economics, 19(1), 155.

    Google Scholar 

  • Cantwell, J., & Mudambi, R. (2005). MNE competence-creating subsidiary mandates. Strategic Management Journal, 26(12), 1109–1128.

    Article  Google Scholar 

  • Carlson, B. (2012). Outsourcing discovery can stretch dollars. Genetic Engineering and Bioengineering News, 32(11), 26.

    Article  Google Scholar 

  • Cesarani, M. (2014). Global network, outsourcing and relationship management. Doctoral thesis. University of Milan-Biocca.

  • Contractor, F. J., Kumar, V., Kundu, S. K., & Pedersen, T. (2010). Reconceptualising the firm in a world of outsourcing and offshoring: The organizational and geographical relocation of high-value company functions. Journal of Management Studies, 47(8), 1417–1433.

    Article  Google Scholar 

  • Contractor, F. J., & Lorange, P. (2002). The growth of alliances in the knowledge-based economy. International Business Review, 11(4), 485–502.

    Article  Google Scholar 

  • Dahlmann, F., & Brammer, S. (2011). Exploring and explaining patterns of adaptation and selection in corporate environmental strategy in the USA. Organization Studies, 32(4), 527–553.

    Article  Google Scholar 

  • De Vita, G., & Wang, C. L. (2006). Development of outsourcing theory and practice: A taxonomy of outsourcing generations. In H. Kehal & V. P. Singh (Eds.), In outsourcing and offshoring in the 21st century: A socio-economic perspective. Hershey: Idea Group Publishing.

    Google Scholar 

  • DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the pharmaceutical industry: new estimates of R&D costs. Journal of Health Economics, 47, 20–33.

    Article  Google Scholar 

  • Dossani, R., & Kenney, M. (2005). The next wave of globalization? Exploring the relocation of service provision to India. Berkeley: Berkeley Roundtable on the International Economy. University of California.

    Google Scholar 

  • Dunning, J. H., & Lundan, S. M. (2009). The internationalization of corporate R&D: a review of the evidence and some policy implications for home countries1. Review of Policy Research, 26(1–2), 13–33.

    Article  Google Scholar 

  • Durand, R. (2006). Organizational evolution and strategic management. London: Sage.

    Google Scholar 

  • Eisenhardt, K. M. (1989). Building theories from case study research. Academy of Management Review, 14(4), 532–550.

    Google Scholar 

  • Eisenhardt, K. M., & Graebner, M. E. (2007). Theory building from cases: Opportunities and challenges. Academy of Management Journal, 50(1), 25–32.

    Article  Google Scholar 

  • European Federation of Pharmaceutical Industries and Associations (2012). http://www.efpia.eu/documents/19/81/The-Pharmaceutical-Industry-in-figures-Edition-2012. Accessed 10 Sept 2016.

  • Farjoun, M., & Starbuck, W. H. (2007). Organizing at and beyond the limits. Organization Studies, 28(4), 541–566.

    Article  Google Scholar 

  • Findlay, S. M. (2007). Outsourcing in Pharma. Pharmaceutical Technology Europe, 19(5), 13–14.

  • Fischer, W. A., & Behrman, J. N. (1979). The coordination of foreign R&D activities by transnational corporations. Journal of International Business Studies, 10(3), 28–34.

    Article  Google Scholar 

  • Flint, D. J., Woodruff, R. B., & Fisher-Gardial, S. (2002). Exploring the phenomenon of customers’ desired value change in a business-to business context. Journal of Marketing, 66(4), 102–117.

    Article  Google Scholar 

  • Flores, R. G., & Aguilera, R. V. (2007). Globalization and location choice: an analysis of US multinational firms in 1980 and 2000. Journal of International Business Studies, 38(7), 1187–1210.

    Article  Google Scholar 

  • Forbes (2014) Global 2000: The Biggest drug Companies of 2014. https://www.forbes.com/pictures/mkg45edhgd/no-1-pfizer/#52e5779c105f. Accessed 13 May 2017.

  • Forero-Pineda, C. (2006). The impact of stronger intellectual property rights on science and technology in developing countries. Research Policy, 35(6), 808–824.

    Article  Google Scholar 

  • Galambos, L., & Sturchio, J. L. (1996). The pharmaceutical industry in the twentieth century: a reappraisal of the sources of innovation. History and Technology, an International Journal, 13(2), 83–100.

    Article  Google Scholar 

  • Gammelgaard, J., & Pedersen, T. (2010). Internal versus external knowledge sourcing of subsidiaries and the impact of headquarters control. In U. Andersson & U. Holm (Eds.), Managing the contemporary multinational: The role of headquarters (pp. 211–230). Northampton: Edward Elgar Publishing.

    Google Scholar 

  • Gehman, J., Trevino, L. K., & Garud, R. (2013). Values work: A process study of the emergence and performance of organizational values practices. Academy of Management Journal, 56(1), 84–112.

    Article  Google Scholar 

  • Ghauri, P. N., & Rao, P. M. (2009). Intellectual property, pharmaceutical MNEs and the developing world. Journal of World Business, 44(2), 206–215.

    Article  Google Scholar 

  • Gibbert, M., Ruigrok, W., & Wicki, B. (2008). What passes as a rigorous case study? Strategic Management Journal, 29(13), 1465–1474.

    Article  Google Scholar 

  • Glickman, S. W., McHutchison, J. G., Peterson, E. D., Cairns, C. B., Harrington, R. A., Califf, R. M., et al. (2009). Ethical and scientific implications of the globalization of clinical research. New England Journal of Medicine, 360(8), 816–823.

    Article  Google Scholar 

  • Gooris, J., & Peeters, C. (2014). Home–host country distance in offshore governance choices. Journal of International Management, 20(1), 73–86.

    Article  Google Scholar 

  • Grimpe, C., & Kaiser, U. (2010). Balancing internal and external knowledge acquisition: The gains and pains from R&D outsourcing. Journal of Management Studies, 47(8), 1483–1509.

    Article  Google Scholar 

  • Haakonsson, S. J., Jensen, P. D. Ø., & Mudambi, S. M. (2013). A co-evolutionary perspective on the drivers of international sourcing of pharmaceutical R&D to India. Journal of Economic Geography, 13(4), 677–700.

    Article  Google Scholar 

  • Haffner, M. E. (2006). Adopting orphan drugs—two dozen years of treating rare diseases. New England Journal of Medicine, 354(5), 445–447.

    Article  Google Scholar 

  • Hannan, M. T., & Freeman, J. (1984). Structural inertia and organizational change. American Sociological Review, 49(2), 149–164.

    Article  Google Scholar 

  • Harrison, D. A., & Klein, K. J. (2007). What’s the difference? Diversity constructs as separation, variety, or disparity in organizations. Academy of Management Review, 32(4), 1199–1228.

    Article  Google Scholar 

  • Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014). Clinical development success rates for investigational drugs. Nature Biotechnology, 32(1), 40.

    Article  Google Scholar 

  • Hitt, M. A., Hoskisson, R. E., & Kim, H. (1997). International diversification: Effects on innovation and firm performance in product diversified firms. Academy of Management Journal, 40(4), 767–798.

    Article  Google Scholar 

  • Hoecht, A., & Trott, P. (2006). Innovation risks of strategic outsourcing. Technovation, 26(5), 672–681.

    Article  Google Scholar 

  • Ingram, P., & Roberts, P. W. (1999). Suborganizational evolution in the US pharmaceutical industry. In J. A. C. Baum & B. McKelvey (Eds.), Variations in organization science: In Honor of Donald T. Campbell. London: Sage.

    Google Scholar 

  • Jones, O. (2000). Innovation management as a post-modern phenomenon: the outsourcing of pharmaceutical R&D. British Journal of Management, 11(4), 341–356.

    Article  Google Scholar 

  • Jung, D. D., Wu, A., & Chow, C. W. (2008). Towards understanding the direct and indirect effects of CEOs’ transformational leadership on firm innovation. The Leadership Quarterly, 19(5), 582–594.

    Article  Google Scholar 

  • Kaitin, K. I. (2010). The landscape for Pharmaceutical Innovation: Drivers of cost-effective clinical research. Pharmaceutical Outsourcing, May–June. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150117/. Accessed 23 May 2016.

  • Kaufmann, L., & Roessing, S. (2005). Managing conflict of interests between headquarters and their subsidiaries regarding technology transfer to emerging markets—a framework. Journal of World Business, 40(3), 235–253.

    Article  Google Scholar 

  • Kedia, B. L., & Mukherjee, D. (2009). Understanding offshoring: A research framework based on disintegration, location and externalization advantages. Journal of World Business, 44(3), 250–261.

    Article  Google Scholar 

  • Kermani, F., & Langer, E. S. (2007). Outsourcing is key to future pharmaceutical R&D strategy. Pharmaceutical Technology Europe, 19(3), 14–15.

    Google Scholar 

  • Kotabe, M., & Mol, M. J. (2009). Outsourcing and financial performance: A negative curvilinear effect. Journal of Purchasing and Supply Management, 15(4), 205–213.

    Article  Google Scholar 

  • Kotabe, M., Mol, M. J., & Ketkar, S. (2008). An evolutionary stage model of outsourcing and competence destruction: A triad comparison of the consumer electronics industry. Management International Review, 48(1), 65–94.

    Article  Google Scholar 

  • Lacity, M. C., Khan, S. A., & Yan, A. (2016). Review of the empirical business services sourcing literature: an update and future directions. Journal of Information Technology, 31(3), 269–328.

    Article  Google Scholar 

  • Lahiri, S., & Kedia, B. L. (2011). Co-evolution of institutional and organizational factors in explaining offshore outsourcing. International Business Review, 20(3), 252–263.

    Article  Google Scholar 

  • Lai, E. L. C., Riezman, R., & Wang, P. (2009). Outsourcing of innovation. Economic Theory, 38(3), 485–515.

    Article  Google Scholar 

  • Langley, A. (1999). Strategies for theorizing from process data. Academy of Management Review, 24, 691–710.

    Google Scholar 

  • Larsen, M., Manning, S., & Pedersen, T. (2013). Uncovering the hidden costs of offshoring: The impact of complexity, design orientation and experience. Strategic Management Journal, 34(5), 533–552.

    Article  Google Scholar 

  • Lewin, A. Y., Massini, S., & Peeters, C. (2009). Why are companies offshoring innovation? The emerging global race for talent. Journal of International Business Studies, 40(6), 901–925.

    Article  Google Scholar 

  • Lewin, A. Y., & Volberda, H. W. (1999). Prolegomena on coevolution: A framework for research on strategy and new organizational forms. Organization Science, 10(5), 519–534.

    Article  Google Scholar 

  • Lewin, A. Y., & Volberda, H. W. (2011). Co-evolution of global sourcing: The need to understand the underlying mechanisms of firm-decisions to offshore. International Business Review, 20(3), 241–251.

    Article  Google Scholar 

  • Macher, J. T., & Boerner, C. (2012). Technological development at the boundaries of the firm: a knowledge-based examination in drug development. Strategic Management Journal, 33(9), 1016–1036.

    Article  Google Scholar 

  • Malerba, F., & Orsenigo, L. (2015). The evolution of the pharmaceutical industry. Business History, 57(5), 664–687.

    Article  Google Scholar 

  • Malnight, T. W. (1996). The transition from decentralized to network-based MNC structures: An evolutionary perspective. Journal of International Business Studies, 27(1), 43–65.

    Article  Google Scholar 

  • Manning, S., Massini, S., & Lewin, A. Y. (2008). A dynamic perspective on next-generation offshoring: The global sourcing of science and engineering talent. Academy of Management Perspectives, 22(3), 35–54.

    Article  Google Scholar 

  • Marshall, D., Mclvor, R., & Lamming, R. (2005). The development of an outsourcing process model. International Journal of Logistics Research and Applications, 8(4), 245–260.

    Article  Google Scholar 

  • Martínez-Noya, A., & García-Canal, E. (2011). Technological capabilities and the decision to outsource/outsource offshore R&D services. International Business Review, 20(3), 264–277.

    Article  Google Scholar 

  • Martinez-Noya, A., Garcia-Canal, E., & Guillen, M. F. (2013). R&D outsourcing and the effectiveness of intangible investments: is proprietary core knowledge walking out of the door? Journal of Management Studies, 50(1), 67–91.

    Article  Google Scholar 

  • McGrath, G. R., & Nerkar, A. (2004). Real options reasoning and a new look at the R&D investment strategies of pharmaceutical firms. Strategic Management Journal, 25(1), 1–21.

    Article  Google Scholar 

  • Mehta, S., & Peters, L. S. (2007). Outsourcing a core competency. Research-Technology Management, 50(3), 28–34.

    Google Scholar 

  • Mendez, A. (2003). The coordination of globalized R&D activities through project teams organization: an exploratory empirical study. Journal of World Business, 38(2), 96–109.

    Article  Google Scholar 

  • Mihalache, O. R., Jansen, J. J., Van Den Bosch, F. A., & Volberda, H. W. (2012). Offshoring and firm innovation: The moderating role of top management team attributes. Strategic Management Journal, 33(13), 1480–1498.

    Article  Google Scholar 

  • Mol, M. J., & Kotabe, M. (2011). Overcoming inertia: Drivers of the outsourcing process. Long Range Planning, 44(3), 160–178.

    Article  Google Scholar 

  • Monin, P., Noorderhaven, N., Vaara, E., & Kroon, D. (2013). Giving sense to and making sense of justice in postmerger integration. Academy of Management Journal, 56(1), 256–284.

    Article  Google Scholar 

  • Morgan, N. A., & Rego, L. L. (2009). Brand portfolio strategy and firm performance. Journal of Marketing, 73(1), 59–74.

    Article  Google Scholar 

  • Mudambi, R., & Venzin, M. (2010). The strategic nexus of offshoring and outsourcing decisions. Journal of Management Studies, 47(8), 1510–1533.

    Article  Google Scholar 

  • Narula, R. (2001). Choosing between internal and non-internal R&D activities: Some technological and economic factors. Technology Analysis and Strategic Management, 13(3), 365–387.

    Article  Google Scholar 

  • Nieto, M. J., & Rodríguez, A. (2011). Offshoring of R&D: Looking abroad to improve innovation performance. Journal of International Business Studies, 42(3), 345–361.

    Article  Google Scholar 

  • Nooteboom, B. (1999). Inter-firm alliances: Analysis and design. London: Routledge.

    Book  Google Scholar 

  • OECD. (2005). Oslo Manual. Guidelines for collecting and interpreting innovation (3rd ed.). Paris: OECD Publications.

    Google Scholar 

  • Oshri, I., Kotlarsky, J., & Willcocks, L. P. (2015). The handbook of global outsourcing and offshoring (3rd ed.). New York: Springer.

    Book  Google Scholar 

  • Ozcan, P., & Eisenhardt, K. M. (2009). Origin of alliance portfolios: Entrepreneurs, network strategies, and firm performance. Academy of Management Journal, 52(2), 246–279.

    Article  Google Scholar 

  • Paju, T. (2007). Conceptual model of R&D offshore outsourcing. Journal of Global Business and Technology, 3(1), 49–61.

    Google Scholar 

  • Peeters, C., Massini, S., & Lewin, A. Y. (2014). Sources of variation in the efficiency of adopting management innovation: The role of absorptive capacity routines, managerial attention and organizational legitimacy. Organization Studies, 35(9), 1343–1371.

    Article  Google Scholar 

  • Petryna, A. (2005). Ethical variability: Drug development and globalizing clinical trials. American Ethnologist, 32(2), 183–197.

    Article  Google Scholar 

  • Petryna, A. (2007). Clinical trials offshored: On private sector science and public health. BioSocieties, 2(1), 21–40.

    Article  Google Scholar 

  • PhRMA. (2007). Pharmaceutical industry profile. Washington, DC: Pharmaceutical Research and Manufacturing of America.

    Google Scholar 

  • PhRMA. (2013). Pharmaceutical industry profile. Washington, DC: Pharmaceutical Research and Manufacturing of America.

    Google Scholar 

  • PhRMA. (2016). Pharmaceutical industry profile. Washington, DC: Pharmaceutical Research and Manufacturing of America.

    Google Scholar 

  • Piachaud, B. (2004). Outsourcing R&D in the pharmaceutical industry: From conceptualization to implementation of the strategic sourcing process. Basingstoke: Palgrave Macmillan.

    Book  Google Scholar 

  • Pisani, N., & Ricart, J. E. (2016). Offshoring of services: a review of the literature and organizing framework. Management International Review, 56(3), 385–424.

    Article  Google Scholar 

  • PWC (2014). From vision to decision pharma 2020. Industry white paper.

  • Quinn, J. B. (2000). Outsourcing innovation: The new engine of growth. Sloan Management Review, 41(4), 13–28.

    Google Scholar 

  • Riege, A. M. (2003). Validity and reliability tests in case study research: a literature review with “hands-on” applications for each research phase. Qualitative Market Research: An International Journal, 6(2), 75–86.

    Article  Google Scholar 

  • Roy, S., & Sivakumar, K. (2011). Managing intellectual property in global outsourcing for innovation generation. Journal of Product Innovation Management, 28(1), 48–62.

    Article  Google Scholar 

  • Sabatier, V., Mangematin, V., & Rousselle, T. (2010). From recipe to dinner: Business model portfolios in the European bio-pharmaceutical industry. Long Range Planning, 43(2–3), 431–447.

    Article  Google Scholar 

  • Sanders, N. R., Locke, A., Moore, C. B., & Autry, C. W. (2007). A multidimensional framework for understanding outsourcing arrangements. Journal of Supply Chain Management, 43(4), 3–15.

    Article  Google Scholar 

  • Sidhu, J. S., & Volberda, H. W. (2011). Coordination of globally distributed teams: A co-evolution perspective on offshoring. International Business Review, 20(3), 278–290.

    Article  Google Scholar 

  • Stake, R. E. (2006). Multiple case study analysis. New York: Guilford Press.

    Google Scholar 

  • Subramaniam, S., & Dugar, S. (2012). Outsourcing drug discovery to India and China: from surviving to thriving. Drug Discovery Today, 17(19–20), 1055–1058.

    Article  Google Scholar 

  • Takeishi, A. (2001). Bridging inter-and intra-firm boundaries: management of supplier involvement in automobile product development. Strategic Management Journal, 22(5), 403–433.

    Article  Google Scholar 

  • Tayles, M., & Drury, C. (2001). Moving from make/buy to strategic sourcing: the outsource decision process. Long Range Planning, 34(5), 605–622.

    Article  Google Scholar 

  • Thakur, P. (2010). Offshoring and outsourcing of core corporate activities: the global relocation of pharmaceutical industry clinical trials. Rutgers University-Graduate School-Newark.

  • Thakur, P. (2012). Backsourcing: A conceptual framework. Working Paper.

  • Thakur, P., & Contractor, F. J. (2012). Impact of offshoring and outsourcing of complex activities on performance: Global clinical trials in pharmaceutical R&D. Working paper.

  • Thiers, F. A., Sinskey, A. J., & Berndt, E. R. (2008). Trends in the globalization of clinical trials. Nature Reviews Drug Discovery, 7(1), 13–14.

    Article  Google Scholar 

  • van de Vrande, V. (2013). Balancing your technology-sourcing portfolio: How sourcing mode diversity enhances innovative performance. Strategic Management Journal, 34(5), 610–621.

    Article  Google Scholar 

  • Veltri, N. F., Saunders, C. S., & Kavan, C. B. (2008). Information systems backsourcing: correcting problems and responding to opportunities. California Management Review, 51(1), 50–76.

    Article  Google Scholar 

  • Volberda, H. W., & Lewin, A. Y. (2003). Co-evolutionary dynamics within and between firms: From evolution to co-evolution. Journal of Management Studies, 40(8), 2111–2136.

    Article  Google Scholar 

  • Voss, C., Tsikriktsis, N., & Frohlich, M. (2002). Case research in operations management. International Journal of Operations and Production Management, 22(2), 195–219.

    Article  Google Scholar 

  • Wassmer, U., Li, S., & Madhok, A. (2016). Resource ambidexterity through alliance portfolios and firm performance. Strategic Management Journal, 38(2), 384–394.

    Article  Google Scholar 

  • Welch, C., Piekkari, R., Plakoyiannaki, E., & Paavilainen-Mäntymäki, E. (2010). Theorizing from case studies: Towards a pluralist future for international business research. Journal of International Business Studies, 42(5), 740–762.

    Article  Google Scholar 

  • Windrum, P., Reinstaller, A., & Bull, C. (2009). The outsourcing productivity paradox: total outsourcing, organisational innovation, and long run productivity growth. Journal of Evolutionary Economics, 19(2), 197–229.

    Article  Google Scholar 

  • Winter, J. E., & Baguley, J. (2006). Outsourcing clinical development: strategies for working with CROs and other partners. Farnham: Gower Publishing Company.

    Google Scholar 

  • Woodward, D., & Rolf, R. (1993). The location of export oriented foreign direct investment in the Caribbean Basin. Journal of International Business Studies, 24(1), 121–144.

    Article  Google Scholar 

  • Wuyts, S., & Dutta, S. (2014). Benefiting from alliance portfolio diversity: The role of past internal knowledge creation strategy. Journal of Management, 40(6), 1653–1674.

    Article  Google Scholar 

  • Yin, R. K. (1994). Case study research: design and methods (Vol. 5)., Applied social research methods series. Biography London: Sage Publications.

    Google Scholar 

  • Yin, R. K. (2003). Case study research: Design and methods. Thousand Oaks: Sage.

    Google Scholar 

  • Zaheer, S. (1995). Overcoming the liability of foreignness. Academy of Management Journal, 38(2), 341–363.

    Article  Google Scholar 

  • Zaheer, S., & Mosakowski, E. (1997). The dynamics of the liability of foreignness: A global study of survival in financial services. Strategic Management Journal, 18(6), 439–463.

    Article  Google Scholar 

  • Zucker, L. G., & Darby, M. R. (1997). Individual action and the demand for institutions star scientists and institutional transformation. American Behavioral Scientist, 40(4), 502–513.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pamplin College of Business, Virginia Tech University, Blacksburg, VA, USA

    Pooja Thakur-Wernz

  2. School of Business, Virginia Commonwealth University, Richmond, VA, USA

    Pooja Thakur-Wernz

  3. College of Business and Economics, West Virginia University, Morgantown, WV, USA

    Olga Bruyaka

Authors
  1. Pooja Thakur-Wernz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olga Bruyaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pooja Thakur-Wernz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thakur-Wernz, P., Bruyaka, O. Co-evolutionary Perspective on Sourcing Portfolios: Examining Sourcing Choices for Clinical Trials of Bio-pharmaceutical Firms. Manag Int Rev 57, 909–946 (2017). https://doi.org/10.1007/s11575-017-0326-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11575-017-0326-y

Keywords

Search

Navigation